Opsens Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 294

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 10

  • Investments
  • 2

Opsens General Information

Description

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.

Contact Information

Website
www.opsens.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 750, du Parc-Technologique Boulevard
  • Quebec, Quebec G1P 4S3
  • Canada
+1 (418)
Primary Industry
Other Commercial Products
Other Industries
Monitoring Equipment
Parent Company
Vertical(s)
Former Stock Listing
OPS
Corporate Office
  • 750, du Parc-Technologique Boulevard
  • Quebec, Quebec G1P 4S3
  • Canada
+1 (418)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Opsens Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Opsens‘s full profile, request access.

Request a free trial

Opsens Patents

Opsens Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4475748-A1 Pressure based structural heart assessment systems and methods Pending 22-Mar-2022
JP-2025510751-A Pressure-based structural cardiac assessment system and method - patent application Pending 22-Mar-2022
US-D921648-S1 Display screen or portion thereof with graphical user interface Active 17-May-2019
US-D921003-S1 Display screen or portion thereof with graphical user interface Active 17-May-2019
US-D926199-S1 Display screen or portion thereof with graphical user interface Active 17-May-2019
To view Opsens’s complete patent history, request access »

Opsens Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Opsens Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Opsens‘s full profile, request access.

Request a free trial

Opsens Acquisitions (2)

Opsens’s most recent deal was a Merger/Acquisition with Inflo Solutions for . The deal was made on 11-Dec-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Inflo Solutions 11-Dec-2007 Merger/Acquisition Electronic Equipment and Instruments
DCB Capital 04-Oct-2006 Merger/Acquisition Other Financial Services
To view Opsens’s complete acquisitions history, request access »

Opsens FAQs

  • When was Opsens founded?

    Opsens was founded in 2003.

  • Where is Opsens headquartered?

    Opsens is headquartered in Quebec, Canada.

  • What is the size of Opsens?

    Opsens has 294 total employees.

  • What industry is Opsens in?

    Opsens’s primary industry is Other Commercial Products.

  • Is Opsens a private or public company?

    Opsens is a Private company.

  • What is the current valuation of Opsens?

    The current valuation of Opsens is .

  • What is Opsens’s current revenue?

    The current revenue for Opsens is .

  • How much funding has Opsens raised over time?

    Opsens has raised $51.6M.

  • Who are Opsens’s investors?

    DCB Capital and Lumira Ventures have invested in Opsens.

  • When was Opsens acquired?

    Opsens was acquired on 12-Dec-2023.

  • Who acquired Opsens?

    Opsens was acquired by Haemonetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »